AtriCure, Inc. is a medical device company providing atrial fibrillation (Afib) solutions. The Company develops, manufactures and sells devices designed for the surgical ablation of cardiac tissue for the treatment of atrial fibrillation and systems designed for the exclusion of the left atrial appendage. The Company’s products include AtriCure’s Synergy Ablation System and Related Radio Frequency (RF) Ablation Devices, Estech’s Radio Frequency Ablation Devices, Cryoablation System and AtriClip Gillinov-Cosgrove Left Atrial Appendage (LAA) System (AtriClip system). In addition, the Company also sells enabling technologies including Lumitip dissector, the MicroPace ORLab system and Estech valve surgical devices. The Company sells its products through a direct sales force and through a wholly owned subsidiary, AtriCure Europe B.V. The Company’s other wholly owned subsidiaries include AtriCure, LLC and Endoscopic Technologies, LLC.